| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.01B | $918.2M | $884.1M |
| YoY Revenue Growth % | +10.4% | +3.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$232.6M | -$230.1M | -$323.4M |
| Operating Margin % | -22.9% | -25.1% | -36.6% |
| Net Income (GAAP) | -$197.1M | -$195.0M | -$274.1M |
| EBITDA (Normalized) | -$196.1M | -$197.0M | -$291.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $321.6M | $283.4M | $295.5M |
| Capital Expenditures (CapEx) | $45.6M | $41.3M | $39.8M |
| Free Cash Flow (FCF) | $276.0M | $242.1M | $255.7M |
| FCF Margin % | 27.2% | 26.4% | 28.9% |
| Return on Invested Capital (ROIC %) | -3.8% | -3.5% | -11.2% |
| Cash & Short-Term Equivalents | $280.2M | $89.9M | — |
| Total Debt (Short + Long Term) | $2.63B | $2.58B | $887.2M |
| Total Stockholders' Equity | $2.45B | $2.76B | $1.82B |